Thought-Controlled Bionic Arm for Arm Amputees
(iSens Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new bionic arm called iSens, designed for thought control and sensory feedback. The aim is to assess the safety and effectiveness of this advanced prosthetic for individuals who have lost an arm. Participants will either use their current prosthesis or try the iSens system for three months. The trial seeks individuals who have had an upper limb amputation for at least six months and currently use or are prescribed a myoelectric prosthesis. As an unphased trial, it offers participants the chance to be at the forefront of innovative prosthetic technology.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you use any active medical devices that are necessary for your health, you may not be eligible to participate.
What prior data suggests that the iSens device is safe for arm amputees?
Research shows that the iSens system, which uses tiny sensors placed in muscles to detect signals, is under study for safety and effectiveness. In earlier studies, these sensors showed promise in helping control prosthetic arms for individuals who have lost an arm. Importantly, the sensors do not require wires to be threaded through the arm or to break the skin, reducing the risk of infection and other complications.
In a small trial, these sensors successfully recorded and transmitted muscle signals without wires. The study reported no serious safety problems, suggesting that the treatment is well-tolerated. While testing of this system continues, the absence of major issues in earlier studies provides reassurance about its safety for future participants.12345Why are researchers excited about this trial?
The iSens system is unique because it allows arm amputees to control a bionic arm using thought, which is a groundbreaking departure from standard prosthetics that rely on muscle movement or mechanical components. This thought-controlled mechanism offers a more natural and intuitive way for users to operate their prosthetic limbs, potentially improving functionality and user satisfaction. Researchers are excited because this approach could significantly enhance the quality of life for amputees by providing a prosthetic solution that closely mimics the natural movement and control of a real arm.
What evidence suggests that the iSens device is effective for arm amputees?
Research has shown that implantable myoelectric sensors (IMES), part of the iSens system tested in this trial, help amputees control prosthetic limbs more naturally. These sensors detect muscle signals directly, enabling users to move the prosthetic arm by simply thinking about the motion. Studies indicate that this technology makes prosthetic use easier and more precise. The iSens system combines these sensors with advanced technology to create an intuitive prosthetic experience. This approach is promising because it aims to make the prosthetic feel more like a natural part of the body. Participants in this trial will either use the iSens system or continue with their own state-of-the-art prosthesis for comparison.12678
Who Is on the Research Team?
Dustin J. Tyler, PhD
Principal Investigator
Louis Stokes VA Medical Center, Cleveland, OH
Are You a Good Fit for This Trial?
This trial is for adults over 21 who have had an upper limb amputation at least 6 months ago and are using or prescribed a myoelectric prosthesis. They must be mentally fit to participate, as confirmed by a psychologist, and have healthy nerves in the affected limb. People with poor wound healing, infections, pregnancy, inability to speak English, arthritis near the implant area or those needing MRI scans can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Implantation
Surgical implant of cuff electrodes on residual nerves and muscle recording electrodes in muscles, connected to an implanted stimulator
Treatment
Participants use the iSens system or their own prosthesis for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- iSens
iSens is already approved in United States for the following indications:
- Residual limb volume measurement
- Control of externally powered prosthetics
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Congressionally Directed Medical Research Programs
Collaborator
United States Department of Defense
Collaborator
Defense Advanced Research Projects Agency
Collaborator